|
Clinical, epidemiological and outcome data |
|||
| Low base excess group |
Normal base excess group |
P value |
|
|
|
|||
| n (%) |
134 (80) |
34 (20) |
|
| Age (years) |
63 ± 19 |
68 ± 14 |
0.15 |
| Gender, male (%) |
49 |
48 |
0.88 |
| APACHE II score |
16 ± 11 |
15 ± 8 |
0.41 |
| APACHE II predicted mortality (%) |
31 ± 27 |
26 ± 21 |
0.33 |
| Actual mortality (%) |
19 |
17 |
0.53 |
| McCabe score |
1.8 ± 0.7 |
1.8 ± 0.8 |
0.62 |
| SOFA score |
5 ± 5 |
4 ± 3 |
0.16 |
| Medical/surgical admission (%) |
47 |
82 |
0.0002 |
| Type of surgical admission |
|||
| Elective (%) |
34 |
15 |
<0.03 |
| Emergency (%) |
15 |
3 |
0.06 |
| Trauma (%) |
3 |
0 |
0.31 |
| Transferred from |
|||
| Emergency department (%) |
40 |
71 |
<0.002 |
| General ward (%) |
11 |
3 |
0.14 |
| Time to intensive care unit admission (hours) |
3 (1 to 5) |
2 (2 to 5) |
0.90 |
| Shock (%) |
46 |
24 |
0.02 |
| Chronic obstructive pulmonary disease (%) |
4 |
38 |
<0.0001 |
| Sepsis (%) |
23 |
21 |
0.75 |
| Stroke |
15 |
6 |
0.09 |
| Mechanical ventilation (%) |
40 |
35 |
0.22 |
| Total bilirubin (mg%) |
1.1 ± 1.2 |
1.1 ± 1.7 |
0.65 |
| Plasma urea (mg%) |
46 ± 31 |
54 ± 32 |
0.24 |
| Plasma creatinine (mg%) |
1.3 ± 0.7 |
1.1 ± 0.5 |
0.26 |
|
APACHE, Acute Physiologic and Chronic Health Evaluation; SOFA, Sepsis-related Organ Failure Assessment. | |||
Tuhay et al. Critical Care 2008 12:R66 doi:10.1186/cc6896 |
|||